Systemic absorption of orally administered neomycin in liver disease.
暂无分享,去创建一个
[1] S. Sherlock,et al. Neomycin in the treatment of hepatic coma. , 1957, Lancet.
[2] S. Sherlock,et al. Electrolyte and circulatory changes in terminal liver failure. , 1956, Lancet.
[3] C. Fisher,et al. Episodic stupor following portacaval shunt; observations on etiology and therapy. , 1956, The New England journal of medicine.
[4] M. H. Lurie,et al. XCVI The Ototoxicity of Dihydrostreptomycin and Neomycin in the Cat , 1953, The Annals of otology, rhinology, and laryngology.
[5] I. F. Volini,et al. Neomycin therapy; its use in virus pneumonia, tuberculosis and diseases caused by gram-negative bacteria. , 1951, Journal of the American Medical Association.
[6] B. Waisbren,et al. A clinical appraisal of neomycin. , 1950, Annals of internal medicine.
[7] S. Waksman,et al. Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms. , 1949, Science.